Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7862]

FDA approves nivolumab and relatlimab-rmbw for unresectable or metastatic melanoma

FDA approves nivolumab and relatlimab-rmbw for unresectable or metastatic melanoma

Drug combination shows effectiveness in patients with recurrent ER-positive endometrial cancer

Drug combination shows effectiveness in patients with recurrent ER-positive endometrial cancer

Pembrolizumab significantly improved DFS versus placebo as adjuvant therapy in patients with stage IB-IIIA NSCLC regardless of PD-L1 expression

Pembrolizumab significantly improved DFS versus placebo as adjuvant therapy in patients with stage IB-IIIA NSCLC...

ICR welcomes OlympiA trial showing targeted drug improves survival in early-stage breast cancer with inherited BRCA1 or BRCA2 mutation

ICR welcomes OlympiA trial showing targeted drug improves survival in early-stage breast cancer with inherited...

Drug prevents human breast cancer recurrence and metastasis

Drug prevents human breast cancer recurrence and metastasis

Stabilising chromosomes to tackle tumours

Stabilising chromosomes to tackle tumours

Researchers reveal strategies for advanced prostate cancer treatment

Researchers reveal strategies for advanced prostate cancer treatment

Sequencing of drug combinations could amplify the anti-tumour immune response in liver cancer

Sequencing of drug combinations could amplify the anti-tumour immune response in liver cancer

Malaria drug could combat chemotherapy-resistant head and neck cancers

Malaria drug could combat chemotherapy-resistant head and neck cancers

Scientists ‘supercharge’ cancer-fighting T cells

Scientists ‘supercharge’ cancer-fighting T cells

More from ecancer